Navigation Links
Most Read Pharmaceutical and Health News - March '13
Date:4/23/2013

AUSTIN, Texas, April 23, 2013 /PRNewswire/ -- dailyRx News Network announced today the most popular health topics viewed and shared during March 2013. dailyRx News publishes and syndicates consumer-centric health information across YouTube, mobile apps, various news aggregators, as well as through a national network of healthcare providers' social media channels.

"As the digital age evolves, a growing number of adults are using their smartphones and tablets to research health news and information," said Donald W. Hackett , CEO and Publisher of dailyRx News. "It is important that on-the-go eHealth consumers have access to a trusted digital health news resource at their fingertips," Hackett added.

According to Pew Research Center's Project for Excellence in Journalism, digital news consumption was up to 50% in 2012, increasing from 44% in 2010. In addition, a study by InSite Consulting found that 42% of people turn to TV as their primary and initial device in breaking news situations, with 66% then using the Internet to further investigate stories.

Health conditions generating notable viewer engagement on dailyRx.com last month included:

March's most-viewed medications included:

Trending health news throughout dailyRx social media included:

About dailyRx News Network
dailyRx News Network is an emerging leader in publishing health news for consumers and patients alike. dailyRx publishes, aggregates, and syndicates doctor-reviewed news covering a wide range of health conditions, medications, over-the-counter products, and nutraceutical compounds. dailyRx's original content is written in positive, unbiased, easy-to-understand language and reviewed for accuracy by doctors, pharmacists, and therapists. dailyRx, Inc. is a Patient Conversation Media company.


'/>"/>
SOURCE dailyRx News Network
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. European Nuclear Medicine / Radiopharmaceuticals Market - Global Trends & Forecasts to 2017
2. Pharmaceutical Companies On Defense As Post-ACA Implementation Continues
3. New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry
4. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisition Of Obagi Medical Products, Inc.
5. Statement from the Cystic Fibrosis Foundation on Promising Phase 2 Clinical Trial Results of Kalydeco and VX-661 (Vertex Pharmaceuticals Inc.)
6. Biopharmaceutical Managed Care Strength Closely Intertwined with Marketplace Success
7. ADial Pharmaceuticals Announces Agreement With FDA For Phase III Trial Of AD04 For Alcohol Use Disorder In Patients Of Targeted Genotypes
8. Comparison of Biopharmaceutical Industry Between China and India 2013
9. Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study
10. Savara Pharmaceuticals Initiates Phase 2 Clinical Trial of AeroVanc for MRSA Lung Infection in Cystic Fibrosis Patients
11. Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2017)... Israel , May 4, 2017  DarioHealth Corp. ... mobile health and big data solutions, today announced that ... A&D Company, and STI Technologies Limited to lower diabetes ... immediately. Through STI,s innoviCares card, which is available throughout ... , DarioHealth customers will be eligible for additional savings ...
(Date:5/3/2017)... May 3, 2017  Kalorama Information notes that ... percent next year and this is projected to ... stem cell (HSCT) or bone marrow transplants require ... are well-suited for this task. This according to ... Kalorama Information. The various PCR-based methodologies, Sanger sequencing ...
(Date:5/2/2017)... , May 2, 2017  George Clinical, a ... region, and Vector Oncology, a ... and data analytics, formally announced today that George Clinical ... the transaction has the dual purpose of strengthening ... led oncology trial delivery solutions throughout the ...
Breaking Medicine Technology:
(Date:5/24/2017)... ... 24, 2017 , ... Accordant Technology, a trusted IT solutions ... an analytics-first approach, layered with machine learning, that provides real-time visibility into the ... cloud to the edge. Through the new partnership, customers get the real-time situational ...
(Date:5/24/2017)... ... ... Lowe is a sought after actor, and also serves as the host of the ... all aspects of life, and a new segment is being developed on podiatry, which ... is essential to people’s overall well-being, and if viewers have feet problems, they may ...
(Date:5/24/2017)... ... , ... Technique, technique, technique – with a dash of common sense. Those ... and exercise or simply lifting heavy objects, advises Dr. Kaliq Chang, interventional pain management ... says. “Improper technique in lifting anything heavy or an attempt to lift too much ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... Axiad ... organizations, today announced CIO Applications magazine has named the company a “Top 25 ... use of the Cloud to help organizations simply and proactively address potential cybersecurity threats ...
(Date:5/23/2017)... ... May 23, 2017 , ... Cambridge, MA, May ... since 2009, according to a Workers Compensation Research Institute (WCRI) study, a contrast ... North Carolina System: CompScope™ Benchmarks, 17th Edition looks at indemnity and medical ...
Breaking Medicine News(10 mins):